Bulgaria has become an important point of discussion in Europe’s growing conversation around MDMA, harm reduction, and responsible psychedelic use. Known globally as “Ecstasy” or “Molly,” 3,4-methylenedioxymethamphetamine (MDMA) has a complex profile—it is both a stimulant and an empathogen, capable of enhancing mood, empathy, and sensory perception. However, without proper knowledge and precautions, its misuse […]